Genetic Technologies Gets Nasdaq Non-compliance Letter | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has received a letter from Nasdaq saying that the firm's shares do not currently meet the exchange's requirements for minimum stockholders' equity.

The Melbourne, Australia-based firm said that the non-compliance was the result of its reported stockholders' equity as of Dec. 31, 2009 falling below the $10 million threshold as required by Nasdaq's rules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.